Sign inJoin waitlistJoin the waitlist

Priscilla Hsue

Chief, Division of Cardiology · UCLA David Geffen School of Medicine/UCLA Medical Center

Credentials: · · ·

History

Division of Cardiology · UCLA David Geffen School of Medicine/UCLA Medical Center
Present
UCLA David Geffen School of Medicine/UCLA Medical Center
Present
Cardiology Division · UCLA David Geffen School of Medicine/UCLA Medical Center
Present

University of California (San Francisco) School of Medicine
2004–2006
Cardiovascular Disease
University of California (San Francisco) School of Medicine
1999–2002
Internal Medicine
University of California (San Francisco) School of Medicine
1996–1999
Univ of California, San Francisco Sch of Med
1992–1996

Research

Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association
Circulation · 2009 · 900 citations
Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy
The Journal of Infectious Diseases · 2008 · 560 citations
Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association
Circulation · 2019 · 549 citations

Steven Deeks
80 papers
Matt Durstenfeld
57 papers · 35 as a fellow
JM
Jeffrey Martin
42 papers
Peter Ganz
35 papers
Peter Hunt
28 papers · 1 as a fellow
Michael Peluso
27 papers · 11 as a fellow
Timothy Henrich
26 papers
Rebecca Scherzer
21 papers
DW
David Waters
17 papers
Scott Lu
16 papers
Ahmed Tawakol
15 papers
Eric Secemsky
15 papers · 8 as a resident

Grants

Reducing Arterial Inflammation Using Eplerenone and Statins to Augment Cardiovascular Health in HIV
National Heart, Lung, and Blood Institute · R01
PI · $773.1K · Massachusetts General Hospital
2026–2031
Evaluation of Glucagon-Like Peptide-1 Receptor Agonist on Pathophysiology of Inflammation and Atherosclerosis in Persons Living With HIV: A Multicenter Randomized Placebo-Controlled Tri
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.3M · University of California Los Angeles
2026–2031
Impact of Treating Asymptomatic CMV Replication on Cardiovascular Risk in Treated HIV Infection
National Heart, Lung, and Blood Institute · R01
PI · $3.7M · University of California, San Francisco
2020–2030
Heart and Lung Outcomes Post-TB (HALO Post-TB)
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.8M · University of California Los Angeles
2024–2029

Clinical trials

Heart Failure Polypill at a Safety Net Hospital
Principal investigator · Completed · Phase 2
University of California, San Francisco
2024–2025
Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
Principal investigator · Recruiting · Phase 2
Priscilla Hsue, MD
2023–2028
Immunomodulation Using VB-201 to Reduce Arterial Inflammation in Treated HIV - VITAL HIV Trial
Principal investigator · Withdrawn · Phase 1, Phase 2
Priscilla Hsue, MD
2022–2027
Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients
Principal investigator · Completed · Phase 2
Priscilla Hsue, MD
2020–2021